Vor Biopharma (VOR) SEC Filings & 10K Form

$1.88
+0.06 (+3.30%)
(As of 04/23/2024 ET)

Recent Vor Biopharma SEC Filings

DateFilerForm TypeView
04/09/2024
3:05 PM
Vor Biopharma (Filer)
Form DEF 14A
04/09/2024
3:07 PM
Vor Biopharma (Filer)
Form DEFA14A
04/09/2024
3:10 PM
Vor Biopharma (Filer)
Form ARS
02/08/2024
4:10 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
4:05 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
4:06 PM
Jorgensen Nathan D. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
4:08 PM
ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
6:38 PM
Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
6:34 PM
Jorgensen Nathan D. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
6:35 PM
ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
6:36 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
4:03 PM
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
8:10 AM
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2023
3:28 PM
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
3:29 PM
Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
3:31 PM
Jorgensen Nathan D. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2023
3:51 PM
Vor Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/11/2023
4:05 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Vor Biopharma (Subject)
Form SC 13D/A
06/09/2023
6:41 AM
Vor Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2023
5:09 PM
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
3:33 PM
Beckman Daniella (Reporting)
Vor Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:VOR) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners